Top Markets
Coin of the day
BioNexus Gene Lab Corporation BioNexus Gene Lab Corporation

BioNexus Gene Lab Corporation

BGLC
Ранг среди акций #18714
BioNexus Gene Lab Corporation, a molecular diagnostics company, focuses on... BioNexus Gene Lab Corporation, a molecular diagnostics company, focuses on developing and commercializing molecular diagnostic tests for the early detection of diseases and personalized health management primarily in Malaysia. Its non-invasive blood tests are used to analyze changes in ribonucleic acid for the detection of Covid-19, Dengue, human immunodeficiency virus, human papillomavirus, and the risk potentiality of cancers diseases. BioNexus Gene Lab Corporation was incorporated in 2017 and is based in Kuala Lumpur, Malaysia with an additional office in Sheridan, Wyoming.
Цена акции
$2.49
Рыночная капитализация
$4.47M
Изменение (1 день)
-4.01%
Изменение (1 год)
678.16%
Страна
MY
Торговля BioNexus Gene Lab Corporation (BGLC)

Категория

Коэффициент P/B для BioNexus Gene Lab Corporation (BGLC)
Коэффициент P/B на March 2026 TTM: 0.59
Согласно последним финансовым отчетам и цене акций BioNexus Gene Lab Corporation, текущий коэффициент P/B (TTM) составляет 0.59. В конце 2023 он составлял 0.95.
История P/B для BioNexus Gene Lab Corporation с 2016 по 2026
Коэффициент P/B в конце каждого года
Год P/B Изменить
2026 (TTM) 0.59 -1.60%
2024 0.60 -36.56%
2023 0.95 -96.17%
2022 24.65 -51.50%
2021 50.81 49.46%
2020 34.00 -79.93%
2019 169.36 76.55%
2018 95.93 -94.47%
2017 1.74K -101.39%
2016 -125.28K 0.00%
Коэффициент P/B для аналогичных компаний или конкурентов
Компания P/B Разница P/B Страна
3.2693 453.74%
US
2.522 327.17%
US
28.6291 4,749.10%
US
3.6303 514.89%
CN
4.5682 673.75%
US